GAS6 and bladder transitional cell carcinoma: The Kaplan‒Meier survival analysis showed that the higher expression of GAS6 was associated with worse OS, progression‐free survival and platinum‐free interval in 406 BLCA patients in the TCGA dataset (Figure 4M; Figure S7A).